In the early stages of CKD, patients typically have elevated levels of circulating inflammatory cytokines, such as tissue necrosis factor alpha (TNF-α), interleukin-6, interferon gamma, and lipopolysaccharide. This evidence concerns the gene TNF and chronic kidney disease.